z-logo
Premium
Quantitation of intrathecal immunoglobulin synthesis – a new empirical formula
Author(s) -
Auer M.,
Hegen H.,
Zeileis A.,
Deisenhammer F.
Publication year - 2016
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.12924
Subject(s) - intrathecal , medicine , cerebrospinal fluid , antibody , cohort , medical diagnosis , gastroenterology , immunology , pathology , surgery
Background and purpose Intrathecal immunoglobulin (Ig) synthesis occurs in various chronic inflammatory neurological diseases. Different formulae have been developed for quantitative determination of Ig synthesis within the cerebrospinal fluid (CSF) compartment. The hyperbolic formula of Reiber is frequently used which, however, returns a considerable number of false positive results in empirical observations. Methods A computerized database of more than 19 000 paired CSF and serum samples was screened for patients presumed negative for local Ig synthesis and a new formula characterizing this collective was calculated. The validity of this formula was confirmed by several validation steps. Results A cohort of 1173 patients with normal CSF findings was used for quantile regression. The 97.5th quantile of the formulaQ lim ( IgX ) = a ×Q alb bwas considered as the cut‐off curve for intrathecal Ig synthesis using different constants a and b for IgG, IgA and IgM. Compared to the Reiber formula, a lower level of false positive results was produced especially for IgM and IgA which was confirmed in a separate clinically well defined validation cohort. In 77 patients with discrepant findings between Reiber and our formula no specific diagnoses were found confirming the low diagnostic value of borderline Ig synthesis. Conclusions A new approximation formula was developed for determination of intrathecal Ig synthesis which produces fewer false positive results without reducing diagnostic sensitivity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here